Written by Steven Hansen
The U.S. new cases 7-day rolling average is 42.7 % HIGHER than the 7-day rolling average one week ago. U.S. deaths due to coronavirus are now 19.5 % HIGHER than the rolling average one week ago. U.S. hospitalizations due to COVID-19 are now 19.0 % HIGHER than the rolling average one week ago. Today’s posts include:
- U.S. Coronavirus New Cases are at a record 153,669
- U.S. Coronavirus deaths today significantly declined to 630
- U.S. Coronavirus hospitalizations are at a record 67,096
- Biden public health advisers reject national ‘lockdown’
- Justice Alito calls Covid restrictions ‘previously unimaginable’, cites danger to religious freedom
- How Pfizer Plans to Distribute Its Vaccine (It’s Complicated)
- Trump Administration Partners with Chain and Independent Community Pharmacies to Increase Access to Future COVID-19 Vaccines
- Immunity From Pfizer-BioNTech COVID Vaccine May Last a Year, Says Scientist Behind the Shot
- Study finds Americans would spend more this holiday if Congress can get out stimulus checks
- Nursing Students Fill Gaps as Pandemic Rages
- COVID-19 fatality rate down 30% since April, study finds
- Fed Warns Assets Face Big Declines If Virus Goes Unchecked
- West Coast states issue travel advisory ahead of Thanksgiving
The recent worsening of the trendlines for new cases should be attributed to going back to college/university, cooler weather causing more indoor activities, possible mutation of the virus, fatigue from wearing masks / social distancing, holiday activities, and continued loosening of regulations designed to slow the coronavirus spread.
My continuing advice is to continue to wash your hands (especially after using the toilet as COVID first sheds in your stool), putting down the toilet seat (as flushing the toilet releases a plume), wear masks, avoid crowds, and maintain social distancing. No handwashing, mask, or social distancing will guarantee you do not get infected – but it sure as hell lowers the risk in all situations – and the evidence to-date shows a lower severity of COVID-19. In addition, certain activities are believed to carry a higher risk – like being inside in air conditioning and removing your mask (such as restaurants, around your children/grandchildren, bars, and gyms). It is all about viral load – and outdoor activities are generally safe if you can maintain social distance.
include($_SERVER[‘DOCUMENT_ROOT’].’/pages/coronavirus1.htm’); ?>
Hospitalizations (grey line) and Mortality (green line) For Week ending 07NOV2020
source: https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/index.html
Coronavirus News You May Have Missed
Biden public health advisers reject national ‘lockdown’ – The Hill
Two public health experts advising President-elect Joe Biden on COVID-19 rejected the idea of “lockdowns” like those seen in the spring to bring down rising case numbers.
Those lockdowns also led to skyrocketing unemployment as businesses were closed down.
Celine Gounder, who sits on Biden’s COVID-19 task force, said on CNBC Friday the panel supports “targeted” closures of businesses that are actually leading to the spread of the virus, including indoor dining.
“Really the consensus is that we need a more nuanced approach. We’ve learned a lot since the spring, and we can be much more targeted geographically, and we can also be more targeted in terms of what we close,” she said.
“I think what we need to be tightening up right now is indoor dining, going to bars, indoor gyms, that sort of thing and we can really keep schools for example open much longer if we tighten up the areas where we’re most likely to see spread.”
Justice Alito calls Covid restrictions ‘previously unimaginable’, cites danger to religious freedom – NBC
Supreme Court Justice Samuel Alito on Thursday sounded an alarm about restrictions imposed because of the coronavirus pandemic, saying they shouldn’t become a “recurring feature after the pandemic has passed.”
“The pandemic has resulted in previously unimaginable restrictions on individual liberty,” Alito said in an address to the conservative Federalist Society, which is holding its annual convention virtually because of the pandemic.
Alito noted that he was “not diminishing the severity of the virus’ threat to public health” or saying anything about “whether any of these restrictions represent good public policy.” He cautioned against his words being “twisted or misunderstood.”
But he said it is an “indisputable statement of fact” that “we have never before seen restrictions as severe, extensive and prolonged as those experienced for most of 2020.”
“Whatever one may think about the COVID restrictions, we surely don’t want them to become a recurring feature after the pandemic has passed,” said Alito, who was nominated to the court by President George W. Bush.
Coronavirus won’t stop many Americans from attending large holiday gatherings, survey finds – Fox
With big holidays coming up at the tail end of 2020, medical experts are worried that Americans traveling for family gatherings on days like Thanksgiving or Christmas could spread COVID-19.
Nearly 40% of Americans will likely attend a gathering with 10 people, according to a new national survey by The Ohio State University Wexner Medical Center. And a third of them reportedly will not ask guests to wear masks.
The findings come as new coronavirus cases are trending up across the U.S. The Centers for Disease Control and Prevention reported more than 143,000 new cases on Wednesday alone, and the virus has so far infected more than 10.3 million Americans and killed more than 241,000.
The CDC recommends precautions like wearing a mask and socially distancing at least 6 feet from people you don’t live with. But as the weather gets colder, gatherings are being forced inside, where the virus can spread more easily, officials warn.
OCD Drug Looks Promising for COVID-19 Outpatients – MedPage
Clinical deterioration was not seen in 80 symptomatic COVID-19 patients who received the selective serotonin reuptake inhibitor (SSRI) fluvoxamine in a randomized trial, compared with six of 72 receiving placebo.
That translated to an absolute difference in risk of 8.7 percentage points (95% CI 1.8-16.4), reported Eric Lenze, MD, of Washington University School of Medicine in St. Louis, Missouri, and colleagues.
More patients in the placebo group also experienced adverse events versus the intervention group, the authors wrote in a preliminary communication in JAMA.
Fed Warns Assets Face Big Declines If Virus Goes Unchecked – Advisor Perspectives
The Federal Reserve is warning that asset prices in key markets could still take a hit if the coronavirus pandemic’s economic impact worsens in coming months.
Most assets have maintained strong levels so far, as investor appetites increased and the government intervened to support the financial system, according to the Fed’s twice-yearly Financial Stability Report released Monday. Signs of weakness are showing in commercial real estate — which has been particularly sensitive to the pandemic — where property values have begun falling, according to the report.
The report also said that hedge fund leverage has remained elevated and that life insurers are reaching debt levels not seen since the 2008 financial crisis.
“Uncertainty remains high, and investor risk sentiment could shift swiftly should the economic recovery prove less promising or progress on containing the virus disappoint,” the Fed said in the report, which is meant to spotlight emerging threats to the financial system. “Some segments of the economy, such as energy as well as travel and hospitality, are particularly vulnerable to a prolonged pandemic.
COVID-19 fatality rate down 30% since April, study finds – Reuters
The likelihood that a coronavirus infection will prove fatal has dropped by nearly a third since April due to improved treatment, researchers at the University of Washington’s Institute for Health Metrics and Evaluation (IHME) said on Thursday.
In the United States, COVID-19 now kills about 0.6% of people infected with the virus, compared with around 0.9% early in the pandemic, IHME Director Dr. Christopher Murray told Reuters.
He said statistics reflect that doctors have figured out better ways to care for patients, including the use of blood thinners and oxygen support. Effective treatments, such as the generic steroid dexamethasone, have also been identified.
Experts have struggled to accurately measure a crucial metric in the pandemic: the fatality rate, or percentage of people infected with the pathogen who are likely to die. The difficulty is exacerbated by the fact that many people who become infected do not experience symptoms and are never identified.
How Pfizer Plans to Distribute Its Vaccine (It’s Complicated) – New York Times
… Pfizer — like other manufacturers that may soon be authorized to roll out their vaccines — does not fully control its own destiny. The effort will hinge on collaboration among a network of companies, federal and state agencies, and on-the-ground health workers in the midst of a pandemic that is spreading faster than ever through the United States.
Before Pfizer can begin shipping its vaccine, federal and state governments must tell it where to send how many doses. McKesson, a major medical supplier, will have to provide hospitals and other distribution sites with the syringes, needles and other supplies necessary to administer the vaccine.
Employees at those locations will need to be trained to store and administer the vaccine. They will also have to ensure that, three weeks after people get the vaccine, they return for a second dose. And millions of Americans must be persuaded to get the shots in the first place.
“We have a lot of confusion at the state and the local health departments level, and a lot of concern about the nitty-gritty of deployment,” said Dr. Saad B. Omer, the director of the Yale Institute for Global Health. “Which places, where to vaccinate, how to get the vaccine there, how to identify people in various risk groups, how to document, how to call back people for the second dose.”
… The particulars of Pfizer’s vaccine will make this effort even more complex. The vaccine, developed with the German company BioNTech, has to be stored at around minus 70 degrees Celsius (minus 94 Fahrenheit) until shortly before it is injected. That is about the temperature of the South Pole on a winter day and colder than any of the other leading vaccines in development.
… Pfizer is making the vaccine at facilities in Kalamazoo, Mich., and Puurs, Belgium. The doses distributed in the United States will mostly come from Kalamazoo.
In Kalamazoo, vaccines will go into vials (five doses per vial). Vials will go into trays (195 vials per tray). Trays will go into specially designed cooler-type boxes (up to five trays per box). Pfizer plans to have about 100,000 of the coolers by the end of this month and more than double that total by March.
The reusable boxes, each toting between 1,000 and 5,000 doses and stuffed with dry ice, are equipped with GPS-enabled sensors. Pfizer employees will be able to monitor the boxes’ locations and temperatures as FedEx and UPS transport them to hospitals and clinics nationwide.
[editor’s note: this article has a lot of meat in it and deserves a full read]
To maximize access to COVID-19 vaccines for all Americans, the U.S. Department of Health and Human Services (HHS) today announced the U.S. government’s partnerships with large chain pharmacies and networks that represent independent pharmacies and regional chains. Through the partnership with pharmacy chains, this program covers approximately 60 percent of pharmacies throughout the 50 states, the District of Columbia, Puerto Rico, and the U.S. Virgin Islands. Through the partnerships with network administrators, independent pharmacies and regional chains will also be part of the federal pharmacy program, further increasing access to vaccine across the country—particularly in traditionally underserved areas.
Below is the list of chain and community-pharmacies networks that have signed on as of November 6
- Albertsons Companies, Inc. (incl., Osco, Jewel-Osco, Albertsons, Albertsons Market, Safeway, Tom Thumb, Star Market, Shaws, Haggen, Acme, Randalls, Carrs, Market Street, United, Vons, Pavilions, Amigos, Lucky’s, Pak n Save, Sav-On)
- Costco Wholesale Corp.
- CPESN USA, LLC
- CVS Pharmacy, Inc. (incl. Long’s)
- Good Neighbor Pharmacy and AmerisourceBergen Drug Corporation’s PSAO, Elevate Provider
- Health Mart Systems, Inc.
- H-E-B, LP
- Hy-Vee, Inc.
- LeaderNET and Medicine Shoppe, Cardinal Health’s PSAOs
- Managed Health Care Associates (MHA)
- Meijer Inc.
- Publix Super Markets, Inc.
- Retail Business Services, LLC (incl., Food Lion, Giant Food, The Giant Company, Hannaford Bros Co, Stop & Shop)
- Rite Aid Corp.
- The Kroger Co. (incl., Kroger, Harris Teeter, Fred Meyer, Frys, Ralphs, King Soopers, Smiths, City Market, Dillons, Marianos, Pick-n-Save, Copps, Metro Market)
- Topco Associates, LLC (incl. Big-Y Pharmacy and Wellness Center, Brookshire’s Pharmacy, Super One Pharmacy, FRESH by Brookshire’s Pharmacy, Coborn’s Pharmacy, Cash Wise Pharmacy, MarketPlace Pharmacy, Hartig Drug Company, King Kullen, Food City Pharmacy, Ingles Pharmacy, Raley’s, Bel Air, Nob Hill Pharmacies, Save Mart Pharmacies, Lucky Pharmacies, SpartanNash, Price Chopper, Market 32, Tops Friendly Markets, ShopRite, Wegmans, Weis Markets, Acme Fresh Markets)
- Walgreens (incl. Duane Reade)
- Walmart, Inc. (incl. Sam’s Club)
- Winn-Dixie Stores Inc. (incl. Winn-Dixie, Harveys, Fresco Y Mas)
Nursing Students Fill Gaps as Pandemic Rages – MedPage
As COVID-19 surges in the U.S., nursing students are still being encouraged to join the front lines, though some program leaders aren’t going along.
Back in June, MedPage Today reported that in official guidelines, nursing leaders encouraged students to enter clinical settings, in contrast to guidance for medical students from the Association of American Medical Colleges at that time (it now supports clinical rotations). Many in both nursing and hospital leadership continue to advocate for that plan.
But in late July, a new guidance written for the American Association of Colleges of Nursing (AACN) by Tener Goodwin Veenema, PhD, of Johns Hopkins University, was more cautious about recommending that nursing students participate in COVID-19 care.
“It may be advisable, in the interest of student safety, to limit student direct care of known or suspected cases of COVID-19 infection until better epidemiologic data are available,” the guidance states. “For now, other than limiting direct care of COVID-19 patients, clinical students should continue their roles as part of the care team.”
What has resulted is variation in policies at nursing programs and their clinical partners, and in support from nursing leadership.
“It’s a better approach for students if they get to finish their studies,” which would include clinical experience, AACN board chair Susan Bakewell-Sachs, PhD, told MedPage Today.
Inhaled Interferon May Aid Hospitalized COVID-19 Patients – MedPage
Hospitalized COVID-19 patients receiving SNG001, inhaled nebulized interferon beta-1a, were more likely to show clinical improvement than those receiving placebo, a small pilot study in the U.K. found.
Patients randomized to receive SNG001 for 14 days had greater odds of improvement on the World Health Organization (WHO) ordinal scale for clinical improvement (OSCI; OR 2.32, 95% CI 1.07-5.04, P=0.033) on day 15 or 16 compared with those receiving placebo, reported Tom Wilkinson, PhD, of University of Southampton in England, and colleagues.
Moreover, patients in the intervention group were more likely to revert to an OSCI score of 1, or no limitation of activities, on day 15 or 16 (HR 2.19, 95% CI 1.03-4.69, P=0.043), the authors wrote in the Lancet Respiratory Medicine.
Type 1 interferon is “one of the first cytokines induced by viral infection of a cell and is a primary driver of innate immune responses in the human lung,” the researchers noted. They explained that SNG001 is a formulation of recombinant interferon beta “for inhaled delivery by [nebulizer],” which has been well tolerated in clinical studies among patients with asthma or chronic obstructive pulmonary disease.
West Coast states issue travel advisory ahead of Thanksgiving – The Hill
West Coast states are jointly asking anyone who arrives from out of state to self-quarantine for 14 days.
The new advisories in California, Washington and Oregon are meant to discourage nonessential travel and apply to both residents and nonresidents.
The travel advisories recommend individuals limit their interactions to their immediate household, defining essential travel as travel for work and study, critical infrastructure support, economic services and supply chains, health, immediate medical care and safety and security.
Immunity From Pfizer-BioNTech COVID Vaccine May Last a Year, Says Scientist Behind the Shot – Newsweek
Uğur Şahin, one of the scientists behind the experimental Pfizer-BioNTech vaccine against COVID, says he hopes it will provide immunity for at least a year, by giving the virus a “bash” on the head.
German biotechnology firm BioNTech and American pharmaceutical giant Pfizer announced in a press release on Monday that their COVID vaccine is 90 percent effective in preventing COVID-19, marking an important milestone in the pandemic that has killed over 1.2 million people worldwide, and seen over 52.8 million infected.
The companies did not release data on the vaccine, and their findings have not been peer-reviewed. If the vaccine meets certain safety criteria, they plan to submit a request for an emergency use authorization to the U.S. Food and Drug Administration. This is expected to happen in the third week of November.
[editor’s note: I am a little wary of this post as the only way one can say immunity lasts for a year is to have a year’s worth of data – other than that, it is only extrapolation of data]
Study finds Americans would spend more this holiday if Congress can get out stimulus checks – CNBC
A fresh round of stimulus checks in Americans’ bank accounts before the end of the year could provide a welcomed boost to retailers this holiday season, according to a new study.
Assuming no additional government stimulus, 37% of consumers said they are likely to spend less money during the holidays, while only 16% plan to spend more on gifts, the Franklin Templeton-Gallup Economics of Recovery study found.
However, assuming there is a $1,200 stimulus payment, the percentage of people planning to spend less falls to 30%, while those planning to dole out more cash on gifts jumps to 22%, according to the poll, which is based on the online responses of 5,002 people from Oct. 1 to Oct. 9.
After the government issued millions of checks to consumers as part of a historic $2 trillion relief package Congress passed in March, consumers were able to shift away from buying only necessities such as groceries and toiletries to splurging on new technology and home improvement items.
The following are foreign headlines with hyperlinks to the posts
The surge of coronavirus cases appears to be slowing in Germany and France, generating hopes that the two European heavyweights are beginning to regain control over the pandemic. But authorities said hospitals are still crowded and are likely to face further strains in the coming weeks,
The U.K. posted its biggest one-day jump in confirmed infections, reporting 33,470 new cases.
In Greece, dozens of medical workers protested at hospitals, demanding more staff be hired as the country struggles to contain a spike of infections that has led to a new lockdown,
India Festival: The crowds filling shopping areas ahead of the Diwali festival of lights are raising hopes of India’s distressed businesses after months of lockdown losses.
World’s Biggest Mink Producer Has ‘No Future’ After Coronavirus
Europe ‘must grit teeth’ on COVID-19 as vaccine euphoria fades
Coronavirus: Video of dead man in hospital lavatory spotlights Italy coronavirus crisis
In China, people are already lining up to receive investigational vaccines not yet approved but nevertheless made available for limited distribution.
Canada’s Ontario province is also considering suspending non-essential surgeries again.
Coronavirus Found In Minks In Greece
Israel contracted to buy enough Pfizer COVID-19 vaccine for 4 million people
Vaccine Works Against Mutated Mink Coronavirus in Early Animal Trials: Danish Scientist
Cuba Leads Race for Latin American Coronavirus Vaccine
Italy registers 550 more deaths; record daily cases in Germany, Sweden and Russia
South Korean Company to Mass Produce Russia’s Coronavirus Vaccine
Covid-19 restrictions in Northern Ireland extended for one more week
UK serial killer “Yorkshire Ripper” dies in hospital after contracting Covid-19
Global drug makers pledge to help deliver potential Covid-19 treatments to poorer countries
The following are additional national and state headlines with hyperlinks to the posts
Costco tightens face-mask rules, and customers with medical conditions are no longer exempt
Global stocks flatline, bond yields slide as caution replaces vaccine euphoria
Cargo Vessels and Cruise Ships Line Up for Scrapping
Amazon, Walmart see online grocery shopping with food stamps surge amid coronavirus
Disneyland Expected to Stay Closed Until At Least Dec. 31
Once a coronavirus hot spot, Massachusetts was seen as a model for infection control this summer as cases and deaths dwindled.
With the recent steady incline in cases, Chicago’s mayor announced a month-long stay-at-home advisory on Thursday and asked residents to cancel Thanksgiving gatherings.
Nurses Reject N.D. Policy on Working While COVID-Positive
California Is 2nd State To Surpass 1 Million Coronavirus Cases
Elon Musk Tests Positive And Negative For Coronavirus, Awaiting Confirmation
Pandemic’s Deadly Toll Behind Bars Spurs Calls For Change In U.S. Jails And Prisons
Judge’s El Paso shutdown order temporarily halted by Texas appeals court
Half of Young Adults Report Struggling With Mental Health During COVID
COVID Research Monkeys Destined for Miami Spur Animal Rights, Legal Battle
Mississippi, Wisconsin, Oklahoma Running Out of ICU Beds Amid COVID Spikes
Don Young, the U.S.’ Oldest Serving Congressman, Tests Positive for COVID
How Jews and Muslims are burying their coronavirus dead
Biden team seeks Covid-19 back-channels with transition locked out
McConnell rejects Dem demand for big Covid relief package, stands by push for ‘highly targeted’ bill
Disney CEO Bob Chapek slams California for ‘arbitrary’ rules keeping park closed
One in four deaths in France are due to Covid-19
Today’s Posts On Econintersect Showing Impact Of The Pandemic With Hyperlinks
06 November 2020 ECRI’s WLI Continues To Improve
October 2020 Producer Price Final Demand Continues To Show Little Year-over-Year Growth
Rail Week Ending 07 November 2020 – Rolling Averages Continue To Improve
Warning to Readers
The amount of politically biased articles on the internet continues to increase. And studies and opinions of the experts continue to contradict other studies and expert opinions. Honestly, it is difficult to believe anything anymore. A study usually cannot establish cause and effect – but only correlation. Be very careful what you believe about this pandemic.
I assemble this coronavirus update daily – sifting through the posts on the internet. I try to avoid politically slanted posts (mostly from CNN, New York Times, and the Washington Post) and can usually find unslanted posts on that subject from other sources on the internet. I wait to publish posts on subjects that I cannot validate across several sources. But after all this extra work, I do not know if I have conveyed the REAL facts. It is my job to provide information so that you have the facts necessary – and then it is up to readers to draw conclusions.
Analyst Opinion of Coronavirus Data
There are several takeaways that need to be understood when viewing coronavirus statistical data:
- The global counts are suspect for a variety of reasons including political. Even the U.S. count has issues as it is possible that as much as half the population has had coronavirus and was asymptomatic. It would be a far better metric using a random sampling of the population weekly. In short, we do not understand the size of the error in the tracking numbers.
- Just because some of the methodology used in aggregating the data in the U.S. is flawed – as long as the flaw is uniformly applied – you establish a baseline. This is why it is dangerous to compare two countries as they likely use different methodologies to determine who has (and who died) from coronavirus.
- COVID-19 and the flu are different but can have similar symptoms. For sure, COVID-19 so far is much more deadly than the flu. [click here to compare symptoms]
- From an industrial engineering point of view, one can argue that it is best to flatten the curve only to the point that the health care system is barely able to cope. This solution only works if-and-only-if one can catch this coronavirus once and develops immunity. In the case of COVID-19, herd immunity may need to be in the 80% to 85% range. WHO warns that few have developed antibodies to COVID-19. At this point, herd immunity does not look like an option although there is now a discussion of whether T-Cells play a part in immunity [which means one might have immunity without antibodies]
- Older population countries will have a higher death rate.
- There are at least 8 strains of the coronavirus. New York may have a deadlier strain imported from Europe, compared to less deadly viruses elsewhere in the United States.
- Each publication uses different cutoff times for its coronavirus statistics. Our data uses 11:00 am London time. Also, there is an unexplained variation in the total numbers both globally and in the U.S.
- The real question remains if the U.S. is over-reacting to this virus. The following graphic from the CDC puts the annual flu burden in perspective [click on image to enlarge]. Note that using this data is dangerous as the actual flu cases are estimated and not counted – nobody knows how accurate these guesses are.
What we do not know about the coronavirus [actually there is little scientifically proven information]. Most of our knowledge is anecdotal, from studies with limited subjects, or from studies without peer review.
- How many people have been infected as many do not show symptoms?
- Masks do work.
- Do we develop lasting immunity to the coronavirus? Another coronavirus – the simple cold – does not develop long term immunity.
- To what degree do people who never develop symptoms contribute to transmission?
- The US has scaled up coronavirus testing – and the accuracy of the tests has been improving. However, if one loses immunity – the coronavirus testing value is reduced.
- Can children widely spread coronavirus? [current thinking is that they are becoming a major source of the pandemic spread]
- Why have some places avoided big coronavirus outbreaks – and others hit hard?
- What effect will the weather have? At this point, it does not seem hot weather slows this coronavirus down – and it seems air conditioning contributes to its spread.
- Outdoor activities seem to be a lower risk than indoor activities.
- Can the world really push out an effective vaccine in 12 to 18 months?
- Will other medical treatments for Covid-19 ease symptoms and reduce deaths? So far only one drug (remdesivir) is approved for treatment.
- A current scientific understanding of the way the coronavirus works can be found [here].
Heavy breakouts of coronavirus have hit farm workers. Farmworkers are essential to the food supply. They cannot shelter at home. Consider:
- they have high rates of the respiratory disease [occupational hazard]
- they travel on crowded buses chartered by their employers
- few have health insurance
- they cannot social distance and live two to four to a room – and they eat together
- some reports say half are undocumented
- they are low paid and cannot afford not to work – so they will go to work sick
- they do not have access to sanitation when working
- a coronavirus outbreak among farmworkers can potentially shutter entire farm
The bottom line is that COVID-19 so far has been shown to be much more deadly than the data on the flu. Using CDC data, the flu has a mortality rate between 0.06 % and 0.11 % Vs. the coronavirus which to date has a mortality rate of 4 % [the 4% is the average of overall statistics – however in the last few months it has been hovering around 1.0%] – which makes it between 10 and 80 times more deadly. The reason for ranges:
Because influenza surveillance does not capture all cases of flu that occur in the U.S., CDC provides these estimated ranges to better reflect the larger burden of influenza.
There will be a commission set up after this pandemic ends to find fault [it is easy to find fault when a once-in-a-lifetime event occurs] and to produce recommendations for the next time a pandemic happens. Those that hate President Trump will conclude the virus is his fault.
Resources:
- Get the latest public health information from CDC: https://www.coronavirus.gov .
- Get the latest research from NIH: https://www.nih.gov/coronavirus.
- Find NCBI SARS-CoV-2 literature, sequence, and clinical content: https://www.ncbi.nlm.nih.gov/sars-cov-2/.
- List of studies: https://icite.od.nih.gov/covid19/search/#search:searchId=5ee124ed70bb967c49672dad
include(“/home/aleta/public_html/files/ad_openx.htm”); ?>